The software provides analysis of HLA typing by NGS on several platforms, including ones from Illumina, Thermo Fisher, and PacBio.
Diagnostic decision support company Variantyx is betting that clinicians need help sorting through NGS data and that the trend is toward whole-genome sequencing.
Work from researchers at Charité in Berlin shows that facial dysmorphology analysis technology may increase the diagnostic rate of exome sequencing.
The Dutch firm plans to develop a complete, CE-marked pipeline for NGS-base HLA typing, from DNA amplification to software analysis.
In a first proof-of-principle, Congenica and Central Manchester University Hospitals NHS Foundation Trust will create a reference laboratory for genomic screening.
A new version of its system planned for summer release will feature a score that helps clinicians prioritize variants and an expanded knowledgebase.
NEW YORK (GenomeWeb) – Syapse said last week that the University of California, San Francisco's Genomic Medicine Initiative and its Helen Diller Family Comprehensive Cancer Center, have selected its cloud-based software to support oncology testing.
The company will use the funds to expand commercialization of its RipSeq software.
The company is targeting its software at oncologists who would use it to develop personalized cancer treatments for individual patients.
Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing.
Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.
Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports.
In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.